BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS
| Image |  |
|---|---|
| Description | scientific article published on 30 October 2020 |
| Author/s |
author: Mikael Cohen Kévin Bigaut Bruno Brochet Clarisse Carra-Dalliere |
| Publication date | October 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |